Prognostic Factors of Human Immunodeficiency Virus-Infected Patients on Chronic Hemodialysis

Background/Aims: The number of human immunodeficiency virus (HIV)-infected patients on hemodialysis (HD) have increased, and their prognostic factors are still poorly clarified. The study aimed to identify factors that can influence the survival of HIV-infected patients on HD. Methods: We performed...

Full description

Saved in:
Bibliographic Details
Published inBlood purification Vol. 44; no. 3; pp. 244 - 250
Main Authors Laranjinha, Ivo, João Matias, Patrícia, Dickson, Jorge, Estibeiro, Hermínia, Boquinhas, Helena, Barata, José Diogo
Format Journal Article
LanguageEnglish
Published Basel, Switzerland 01.01.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background/Aims: The number of human immunodeficiency virus (HIV)-infected patients on hemodialysis (HD) have increased, and their prognostic factors are still poorly clarified. The study aimed to identify factors that can influence the survival of HIV-infected patients on HD. Methods: We performed a retrospective cohort study of 44 HIV-infected patients on HD. Results: A total of 17 patients (39%) died. Median survival on HD was 30.8 months and the survival rate at 1 and 5 years was 82.5 and 62.9%, respectively. Male (relative risk [RR] 3.1, p = 0.040) and blacks (RR 2.5, p = 0.037) had higher risk of death. The patients who died had a shorter duration of HIV infection (p = 0.028), had a higher viral load (p = 0.044), more opportunistic infections (p = 0.013), and a lower serum albumin (p = 0.009). Lower serum albumin, nonsexual HIV transmission, viral load, opportunistic infections, and usage of catheters were associated with lower survival. Conclusion: Several demographic, viral, and dialysis variables may help to predict survival of this population. The intervention in these factors could improve their prognosis.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0253-5068
1421-9735
DOI:10.1159/000478966